Gender Dysphoria and Disorders of Sex Development ― Progress in Care and Knowledge

This book offers expert coverage of developmental trajectories, comorbid conditions, current medical and psychological treatments, and an instructive history of professional conceptualizations of gender dysphoria (GD) and disorders of sex development (DSD).

Baudewijntje P.C. Kreukels, PhD ia a senior researcher at VU University Medical Center, Amsterdam, the Netherlands Department of Medical Psychology, Center of Expertise on Gender Dysphoria, Neuroscience Campus Amsterdam Hormones & Brain. Dr. Kreukels is also Editor Neuropraxis, a Dutch journal on Neuroscience and in 2011 guest editor-in-chief special issue neuroendocrinology. Dr. Kreukels is a member of the International Academy of Sex Research, Dutch Society for Neuropsychology, Network LGBT Research, and the Dutch Neurofederation.Thomas D. Steensma, PhD is a clinical psychologist at the VU Medical Center in The Netherlands. He received his master degree in clinical and social psychology from the University of Amsterdam. He is an associate member of the International Academy of Sex Research.Annelou de Vries, MD, PhD is a child and adolescent psychiatrist working at the VU University Medical Center in Amsterdam. The scope of her work is consultative-liaison psychiatry at the Pediatric department, focusing on sick children with mental health problems. An important and special part of her work is dedicated to gender dysphoric adolescents. At the Amsterdam Gender Identity Clinic (Center of Expertise on Gender Dysphoria), adolescents with a gender identity disorder may be eligible for the complete reversible medical treatment with GnRH analogues to block puberty from age 12 on to create rest and time to make a balanced decision about the irreversible gender reassignment when adolescents reach adulthood. Apart from her clinical work with these gender dysphoric adolescents, Annelou de Vries is also involved in research and published several studies on mental health of gender dysphoric adolescents and treatment evaluation of this GnRH analogue treatment.